Anti-beta2GPI-antibody-induced endothelial cell gene expression profiling reveals induction of novel pro-inflammatory genes potentially involved in primary antiphospholipid syndrome.

2.50
Hdl Handle:
http://hdl.handle.net/2436/29438
Title:
Anti-beta2GPI-antibody-induced endothelial cell gene expression profiling reveals induction of novel pro-inflammatory genes potentially involved in primary antiphospholipid syndrome.
Authors:
Hamid, Colleen G.; Norgate, K.; D'Cruz, D.P.; Khamashta, M.A.; Arno, M.; Pearson, J.D.; Frampton, Geoffrey; Murphy, John J.
Abstract:
OBJECTIVE: To determine the effects of primary antiphospholipid syndrome (PAPS)-derived anti-beta(2)GPI antibodies on gene expression in human umbilical vein endothelial cells (HUVEC) by gene profiling using microarrays. METHODS: Anti-beta(2)GPI antibodies purified from sera of patients with PAPS or control IgG isolated from normal subjects were incubated with HUVEC for 4 h before isolation of RNA and processing for hybridisation to Affymetrix Human Genome U133A-2.0 arrays. Data were analysed using a combination of the MAS 5.0 (Affymetrix) and GeneSpring (Agilent) software programmes. For selected genes microarray data were confirmed by real-time PCR analysis or at the protein level by ELISA. RESULTS: A total of 101 genes were found to be upregulated and 14 genes were downregulated twofold or more in response to anti-beta(2)GPI antibodies. A number of novel genes not previously associated with APS were induced, including chemokines CCL20, CXCL3, CX3CL1, CXCL5, CXCL2 and CXCL1, the receptors Tenascin C, OLR1, IL-18 receptor 1, and growth factors CSF2, CSF3 IL-6, IL1beta and FGF18. The majority of downregulated genes were transcription factors/signalling molecules including ID2. Quantitative real-time RT-PCR analysis confirmed the microarray results for selected genes (CSF3, CX3CL1, FGF18, ID2, SOD2, Tenascin C). CONCLUSIONS: This study reveals a complex gene expression response in HUVEC to anti-beta(2)GPI antibodies with multiple chemokines, pro-inflammatory cytokines, pro-thrombotic and pro-adhesive genes regulated by these antibodies in vitro. Some of these newly identified anti-beta(2)GPI antibody-regulated genes could contribute to the vasculopathy associated with this disease.
Citation:
Annals of the Rheumatic Diseases, 66 (8): 1000-7
Publisher:
BMJ Publishing & European League Against Rheumatism
Journal:
Annals of the Rheumatic Diseases
Issue Date:
2007
URI:
http://hdl.handle.net/2436/29438
DOI:
10.1136/ard.2006.063909
PubMed ID:
17223652
Additional Links:
http://ard.bmj.com/cgi/content/full/66/8/1000
Type:
Article
Language:
en
ISSN:
0003-4967
Appears in Collections:
Food Biology, Medical Microbiology and Disinfection Research Group

Full metadata record

DC FieldValue Language
dc.contributor.authorHamid, Colleen G.-
dc.contributor.authorNorgate, K.-
dc.contributor.authorD'Cruz, D.P.-
dc.contributor.authorKhamashta, M.A.-
dc.contributor.authorArno, M.-
dc.contributor.authorPearson, J.D.-
dc.contributor.authorFrampton, Geoffrey-
dc.contributor.authorMurphy, John J.-
dc.date.accessioned2008-06-04T09:34:40Z-
dc.date.available2008-06-04T09:34:40Z-
dc.date.issued2007-
dc.identifier.citationAnnals of the Rheumatic Diseases, 66 (8): 1000-7en
dc.identifier.issn0003-4967-
dc.identifier.pmid17223652-
dc.identifier.doi10.1136/ard.2006.063909-
dc.identifier.urihttp://hdl.handle.net/2436/29438-
dc.description.abstractOBJECTIVE: To determine the effects of primary antiphospholipid syndrome (PAPS)-derived anti-beta(2)GPI antibodies on gene expression in human umbilical vein endothelial cells (HUVEC) by gene profiling using microarrays. METHODS: Anti-beta(2)GPI antibodies purified from sera of patients with PAPS or control IgG isolated from normal subjects were incubated with HUVEC for 4 h before isolation of RNA and processing for hybridisation to Affymetrix Human Genome U133A-2.0 arrays. Data were analysed using a combination of the MAS 5.0 (Affymetrix) and GeneSpring (Agilent) software programmes. For selected genes microarray data were confirmed by real-time PCR analysis or at the protein level by ELISA. RESULTS: A total of 101 genes were found to be upregulated and 14 genes were downregulated twofold or more in response to anti-beta(2)GPI antibodies. A number of novel genes not previously associated with APS were induced, including chemokines CCL20, CXCL3, CX3CL1, CXCL5, CXCL2 and CXCL1, the receptors Tenascin C, OLR1, IL-18 receptor 1, and growth factors CSF2, CSF3 IL-6, IL1beta and FGF18. The majority of downregulated genes were transcription factors/signalling molecules including ID2. Quantitative real-time RT-PCR analysis confirmed the microarray results for selected genes (CSF3, CX3CL1, FGF18, ID2, SOD2, Tenascin C). CONCLUSIONS: This study reveals a complex gene expression response in HUVEC to anti-beta(2)GPI antibodies with multiple chemokines, pro-inflammatory cytokines, pro-thrombotic and pro-adhesive genes regulated by these antibodies in vitro. Some of these newly identified anti-beta(2)GPI antibody-regulated genes could contribute to the vasculopathy associated with this disease.en
dc.language.isoenen
dc.publisherBMJ Publishing & European League Against Rheumatismen
dc.relation.urlhttp://ard.bmj.com/cgi/content/full/66/8/1000en
dc.subject.meshAdulten
dc.subject.meshAntigen-Antibody Reactionsen
dc.subject.meshAntiphospholipid Syndromeen
dc.subject.meshAutoantibodiesen
dc.subject.meshCase-Control Studiesen
dc.subject.meshDown-Regulationen
dc.subject.meshE-Selectinen
dc.subject.meshEndothelial Cellsen
dc.subject.meshFemaleen
dc.subject.meshGene Expression Profilingen
dc.subject.meshHumansen
dc.subject.meshImmunoglobulin Gen
dc.subject.meshInterleukin-8en
dc.subject.meshMiddle Ageden
dc.subject.meshOligonucleotide Array Sequence Analysisen
dc.subject.meshbeta 2-Glycoprotein Ien
dc.titleAnti-beta2GPI-antibody-induced endothelial cell gene expression profiling reveals induction of novel pro-inflammatory genes potentially involved in primary antiphospholipid syndrome.en
dc.typeArticleen
dc.identifier.journalAnnals of the Rheumatic Diseasesen

Related articles on PubMed

All Items in WIRE are protected by copyright, with all rights reserved, unless otherwise indicated.